Cargando…

Troponin and BNP are markers for subsequent non-ischaemic congestive heart failure: the Caerphilly Prospective Study (CaPS)

OBJECTIVE: To examine the long-term predictive value of 28 biomarkers for subsequent non-ischaemic congestive heart failure (CHF) and separately for other cardiovascular outcomes (myocardial infarction (MI) and stroke). METHODS: The Caerphilly Prospective Study recruited 2171 men aged 55–69 years fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patterson, Christopher C, Blankenberg, Stefan, Ben-Shlomo, Yoav, Heslop, Luke, Bayer, Anthony, Lowe, Gordon, Zeller, Tanja, Gallacher, John, Young, Ian, Yarnell, John W G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845403/ https://www.ncbi.nlm.nih.gov/pubmed/29531757 http://dx.doi.org/10.1136/openhrt-2017-000692

Ejemplares similares

Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS)
por: Patterson, Christopher C., et al.
Publicado: (2015)

Decrease in exhaled hydrogen as marker of congestive heart failure
por: Shibata, Atsushi, et al.
Publicado: (2018)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
por: Wolodimeroff, Elena, et al.
Publicado: (2022)

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
por: Salah, Khibar, et al.
Publicado: (2019)

Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial
por: Vanezis, Andrew Peter, et al.
Publicado: (2018)

IGFBP7 as a preoperative predictor of congestive acute kidney injury after cardiac surgery
por: MacMillan, Yannick S, et al.
Publicado: (2022)

Early prediction of left ventricular function improvement in patients with new-onset heart failure and presumed non-ischaemic aetiology
por: Goh, Ze Ming, et al.
Publicado: (2023)

Association of peripartum troponin I levels with left ventricular relaxation in women with hypertensive disorders of pregnancy
por: Umazume, Takeshi, et al.
Publicado: (2018)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
por: Spurney, Christopher F, et al.
Publicado: (2021)

Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock
por: Haberkorn, Sandra, et al.
Publicado: (2020)

MRI and serum high-sensitivity C reactive protein predict long-term mortality in non-ischaemic cardiomyopathy
por: Sadahiro, Taketaro, et al.
Publicado: (2015)

The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure
por: Binas, David, et al.
Publicado: (2018)

BEHIND THE SCREEN: A RETROSPECTIVE COMPARATIVE ANALYSIS OF CONGESTIVE HEART FAILURE EXACERBATION ADMISSIONS, FOLLOW UP AND MANAGEMENT DURING THE COVID19 PANDEMIC AND PRE PANDEMIC
por: Chebaya, Philip, et al.
Publicado: (2022)

A COMBINED APPROACH USING HIGH-SENSITIVE TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE FOR RISK STRATIFICATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019
por: Sano, Madoka, et al.
Publicado: (2023)

CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis
por: Chevalier, Céleste, et al.
Publicado: (2022)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

COMPARATIVE BURDEN OF DELAYED MYOCARDITIS AFTER SARS COV2 AND OTHER ACUTE RESPIRATORY VIRAL INFECTION
por: Begur, Maedha, et al.
Publicado: (2023)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

OUTCOMES IN THE OUTPATIENT MANAGEMENT OF HEART FAILURE PATIENTS DURING THE COVID-19 PANDEMIC AFTER ROBUST ADOPTION OF A TELEHEALTH MODEL
por: Sammour, Yasser, et al.
Publicado: (2021)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team
por: Masters, Jayne, et al.
Publicado: (2017)

Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019)

Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
por: Massey, Richard John, et al.
Publicado: (2021)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Patient characteristics, short-term and long-term outcomes after incident heart failure admissions in a regional Australian setting
por: Al-Omary, Mohammed S, et al.
Publicado: (2022)

Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
por: Lampropulos, Julianna F, et al.
Publicado: (2014)

Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
por: Klein, Allan L, et al.
Publicado: (2021)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Research priorities in advanced heart failure: James Lind alliance priority setting partnership
por: Taylor, Clare J, et al.
Publicado: (2020)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients
por: McCoy, Jodi, et al.
Publicado: (2017)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gg34q84q02sm3je1uu7b6lb7h2